Neurochemistry
- Endocannabinoid System: Chemical Characteristics and Biological Activity (27 Feb 2023)
- Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review (27 Feb 2023)
- Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies (27 Feb 2023)
- Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance (27 Nov 2022)
- Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells (27 Nov 2022)
- A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications (27 Nov 2022)
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells (05 Sep 2022)
- The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies (05 Sep 2022)
- Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? (05 Sep 2022)
- Kahweol, a natural diterpene from coffee, induces peripheral antinociception by endocannabinoid system activation (05 Sep 2022)
- CB2 Receptor Involvement in the Treatment of Substance Use Disorders (05 Sep 2022)
- N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors (01 Sep 2022)
- Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses (01 Sep 2022)
- Identification of Novel Antagonists Targeting Cannabinoid Receptor 2 Using a Multi-Step Virtual Screening Strategy (01 Sep 2022)
- CB2 Receptor in Microglia: The Guardian of Self-Control (01 Sep 2022)
- Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression (27 Aug 2022)
- New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence (27 Aug 2022)
- Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases (27 Aug 2022)
- 1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists (27 Aug 2022)
- Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition (13 Aug 2022)
- Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation (13 Aug 2022)
- The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation (05 Aug 2022)
- Targeting the Endocannabinoidome in Pancreatic Cancer (05 Aug 2022)
- MD Simulations Revealing Special Activation Mechanism of Cannabinoid Receptor 1 (05 Aug 2022)
- Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures (05 Aug 2022)
- Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option? (05 Aug 2022)
- Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis (05 Aug 2022)
- Synaptic changes induced by cannabinoid drugs and cannabis use disorder (31 Jul 2022)
- Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action (31 Jul 2022)
- Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review (31 Jul 2022)
- Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty (31 Jul 2022)
- Effects of Cannabidiol on Locomotor Activity (31 Jul 2022)
- Cannabinoids for the Treatment of Dermatologic Conditions (31 Jul 2022)
- A critical review of cannabis in medicine and dentistry: A look back and the path forward (31 Jul 2022)
- Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story? - Journal of Cannabis Research (26 Jul 2022)
- CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature - Journal of Cannabis Research (26 Jul 2022)
- A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function - Journal of Cannabis Research (26 Jul 2022)
- Endocannabinoid System and Migraine Pain: An Update (25 Jul 2022)
- Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo (25 Jul 2022)
- Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review (21 Jul 2022)
- Endocannabinoid Discovery Timeline (21 Jul 2022)
- Coffee & Cannabis (21 Jul 2022)
- CBD & the Psychedelic Receptor (21 Jul 2022)
- CBD & Cannabis for Endometriosis (21 Jul 2022)
- Caffeine, ADHD & the CB1 Receptor (21 Jul 2022)
- Cannabinoids: The Science Behind Medical Cannabis (20 Jul 2022)
- Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (20 Jul 2022)
- What Is CBC Oil Good For? Benefits, Uses, & Effects (18 Jul 2022)
- The Role of Cannabinoid Receptors (18 Jul 2022)
- Endocannabinoid System (18 Jul 2022)
- Cresco Labs (18 Jul 2022)